Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol

Robert T Woods, Errollyn Bruce, Rhiannon T Edwards, Barry Hounsome, John Keady, Esme D Moniz-Cook, Martin Orrell, Ian T Russell, Robert T Woods, Errollyn Bruce, Rhiannon T Edwards, Barry Hounsome, John Keady, Esme D Moniz-Cook, Martin Orrell, Ian T Russell

Abstract

Background: The growing number of people with dementia, and the increasing cost of care, provides a major incentive to develop and test methods of supporting them in the community for longer. Most attention has been given to pharmacological interventions, but there is increasing recognition that psychosocial interventions may be equally effective, even preferable where medication has negative side-effects. Reminiscence groups, run by professionals and volunteers, which use photographs, recordings and other objects to trigger personal memories are probably the most popular therapeutic approach to working with people with dementia, but there is little evidence for their effectiveness and cost-effectiveness. The recent inclusion of family carers in groups with people with dementia, notably in our own pilot studies, has generated informal evidence that this joint approach improves relationships between people with dementia and their carers, and benefits both.

Design and methods: This multi-centre, pragmatic randomised controlled trial (RCT) to assess the effectiveness and cost-effectiveness of joint reminiscence groups for people with dementia and their family care-givers has two parallel arms--an intervention group and a control group who receive care as usual. The intervention consists of joint reminiscence groups held weekly for twelve consecutive weeks, followed by monthly maintenance sessions for a further seven months.The primary outcome measures are the quality of life of people with dementia, as assessed by QoL-AD, and their care-givers' mental health as assessed by the GHQ-28. Secondary outcomes include: the autobiographical memories of people with dementia; the quality of the relationship between them and their care-givers; and the levels of depression and anxiety felt by them and their care-giver. Using a 5% significance level, comparison of 200 pairs attending joint reminiscence groups with 200 pairs receiving usual treatment will yield 80% power to detect a standardised difference of 0.38 in the QoL-AD rated by the person with dementia and 0.28 in the GHQ-28 or carer-rated QoL-AD. The trial will include a cost-effectiveness analysis from a public sector perspective.

Discussion: Our Cochrane review (2005) on reminiscence therapy for people with dementia did not identify any rigorous trials or economic analyses in this field.

Trial registration: ISRCTN42430123.

Figures

Figure 1
Figure 1
Flow diagram for the trial.

References

    1. Brodaty H, Green A, Koschera A. Meta-analysis of psychosocial interventions for caregivers of people with dementia. JAGS. 2003;51:657–664. doi: 10.1034/j.1600-0579.2003.00210.x.
    1. Spector A, Thorgrimsen L, Woods B, Royan L, Davies S, Butterworth M, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled tria. Brit J Psychiat. 2003;183:248–254. doi: 10.1192/bjp.183.3.248.
    1. National Institute for Health and Clinical Excellence and the Social Care Institute for Excellence (NICE-SCIE) Dementia: supporting people with dementia and their carers in health and social care. Clinical Guideline 42. London: NICE-SCIE; 2006.
    1. McShane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow-up. BMJ. 1997;314:266–270.
    1. Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. American Journal of Psychiatry. 2005;162:1996–2021. doi: 10.1176/appi.ajp.162.11.1996.
    1. Woods RT. Non-pharmacological techniques. In: Qizilbash N, editor. Evidence-based dementia practice. Oxford: Blackwell; 2002. pp. 428–446.
    1. Clare L, Woods B. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2003;4:CD003260.
    1. Woods B, Spector A, Prendergast L, Orrell M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2005;4:CD005562.
    1. Dementia Services Development Centre (DSDC)-Wales Services for people with dementia in Wales Report No 1: Residential and nursing home care in Wales Bangor. 2002.
    1. Gibson F. The past in the present: using reminiscence in health and social care. Baltimore: Health Professions Press; 2004.
    1. Woods RT, McKiernan F. Evaluating the impact of reminiscence on older people with dementia. In: Haight BK, Webster J, editor. The art and science of reminiscing: theory, research, methods and applications. Washington DC: Taylor & Francis; 1995. pp. 233–242.
    1. Woods B, Spector AE, Jones CA, Orrell M, Davies SP. Reminiscence therapy for people with dementia (review) Cochrane Database Syst Rev. 2005;2:CD001120.
    1. Schweitzer P, Bruce E. Remembering Yesterday, Caring Today: Reminiscence in Dementia Care – A Guide to Good Practice. UK: Jessica Kingsley Publishers; 2008. p. 224.
    1. Bruce E, Gibson F. Remembering Yesterday, Caring Today: Evaluators' Report. London: Age Exchange; 1998.
    1. Thorgrimsen L, Schweitzer P, Orrell M. Evaluating reminiscence for people with dementia: a pilot study. Arts Psychother. 2002;29:93–97. doi: 10.1016/S0197-4556(01)00135-6.
    1. Nolan M, Davies S, Ryan T, Keady J. Relationship-centred care and the 'senses' framework. Journal of Dementia Care. 2008;16:26–28.
    1. Tuokko H, MacCourt P, Heath Y. Home alone with dementia. Aging Ment Health. 1999;3:21–27. doi: 10.1080/13607869956406.
    1. Office of Public Sector Information (OPSI) Mental Capacity Act 2005.
    1. Logsdon RG, Gibbons LE, McCurry SM, Teri L. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510–519.
    1. Thorgrimsen L, Selwood A, Spector A, Royan L, de-Madariaga-Lopez M, Woods RT, et al. Whose quality of life is it anyway? The validity and reliability of the Quality of Life – Alzheimer's Disease (QoL-AD) Scale. Alz Dis Assoc Dis. 2003;17:201–208. doi: 10.1097/00002093-200310000-00002.
    1. Hoe J, Hancock GA, Livingston G, Orrell M. Quality of life of people with dementia in residential care homes. Brit J Psychiat. 2006;188:460–464. doi: 10.1192/bjp.bp.104.007658.
    1. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9:139–145. doi: 10.1017/S0033291700021644.
    1. Donaldson C, Tarrier N, Burns A. Determinants of carer stress in Alzheimer's disease. Int J Geriatr Psychiatry. 1998;13:248–256. doi: 10.1002/(SICI)1099-1166(199804)13:4<248::AID-GPS770>;2-0.
    1. Marriott A, Donaldson C, Tarrier N, Burns A. Effectiveness of cognitive-behavioural family intervention in reducing the burden of care in carers of patients with Alzheimer's disease. Brit J Psychiat. 2000;176:557–562. doi: 10.1192/bjp.176.6.557.
    1. Kopelman MD, Wilson BA, Baddeley A. The Autobiographical Memory Interview. Bury St Edmunds: Thames Valley Test Company; 1990.
    1. Spruytte N, Van-Audenhove C, Lammertyn F, Storms G. The quality of the caregiving relationship in informal care for older adults with dementia and chronic psychiatric patients. Vol. 75. Psychology & Psychotherapy: Theory, Research & Practice; 2002. pp. 295–311.
    1. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiat. 1988;23:271–284. doi: 10.1016/0006-3223(88)90038-8.
    1. Shankar KK, Walker M, Frost D, Orrell MW. The development of a valid and reliable scale for rating anxiety in dementia (RAID) Aging Ment Health. 1999;3:39–49. doi: 10.1080/13607869956424.
    1. Flint AJ, Rifat SL. Validation of the Hospital Anxiety and Depression Scale as a measure of severity of geriatric depression. Int J Geriatr Psychiatry. 1996;11:991–994. doi: 10.1002/(SICI)1099-1166(199611)11:11<991::AID-GPS423>;2-8.
    1. Agar S, Moniz-Cook E, Orbell S, Elston C, Wang M. Measuring the outcome of psychosocial intervention for family caregivers of dementia sufferers: a factor analytic study. Aging Ment Health. 1997;1:166–175. doi: 10.1080/13607869757263.
    1. EuroQol EQ-5D
    1. Bucks RS, Ashworth DL, Wilcock GK, Siegfried K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing. 1996;25:113–120. doi: 10.1093/ageing/25.2.113.
    1. Beecham J, Knapp M. Measuring Mental Health Needs. London: Gaskell; 1992. Costing psychiatric interventions; pp. 163–183.
    1. Knapp M, Thorgrimsen L, Patel A, Spector A, Hallam A, Woods B, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Brit J Psychiat. 2006;188:574–580. doi: 10.1192/bjp.bp.105.010561.
    1. Woods RT, Wills W, Higginson I, Hobbins J, Whitby M. Support in the community for people with dementia and their carers: a comparative outcome study of specialist mental health service interventions. Int J Geriatr Psychiatry. 2003;18:298–307. doi: 10.1002/gps.822.
    1. Glick HA, Doshi JA, Sonnas SS, Polsky D. Economic Evaluation in Clinical Trials. Oxford: Oxford University Press; 2007.
    1. Mistry H, Buxton M, Longworth L, Chatwin J, Peveler R, on behalf of the AHEAD research team Comparison of general practioner records and patient self-report questionnaires for the estimation of costs. Eur J Health Econom. 2005;50:261–266. doi: 10.1007/s10198-005-0300-7.
    1. Curtis L. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Kent; 2008.
    1. Department of Health 2005.
    1. Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves – facts fallacies and frequently asked questions. Health Econ. 2004;13:405–415. doi: 10.1002/hec.903.
    1. Bell CM, Araki SS, Neumann PJ. The association between care-giver burden and care-giver Health related Quality of Life, in Alzheimer Disease. Alzheimer Dis Assoc Disord. 2001;15:129–136. doi: 10.1097/00002093-200107000-00004.
    1. Dixon S, Walker M, Salek S. Incorporating carer effects into economic evaluation. Pharmaeconomics. 2006;24:39–41. doi: 10.2165/00019053-200624010-00003.
    1. National Institute for Health and Clinical Excellence (NICE) Guide to the Methods of Technology Appraisal. London: NICE; 2004. p. 22.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner